Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26F8ZLU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,676
Award facts
- Contract value 100% obligated
- $19,676.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,676.09 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injections on November 12, 2025, with completion expected by November 13, 2025. This competitive award, which carries no set-aside designation, is structured as a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a critical federal medical supplier.
This delivery order represents a routine procurement action within AmerisourceBergen's expansive $999,999,999.00 IDC vehicle with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally. Dupixent is a specialty biologic medication used primarily to treat atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, reflecting the breadth of therapeutic medications the company supplies to support Defense Health Agency and military healthcare operations. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen has demonstrated consistent capability to compete for and execute diverse medical supply contracts across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F8ZLU?
SPE2DR26F8ZLU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26F8ZLU worth?
The government has obligated $19,676 on SPE2DR26F8ZLU.
Is contract SPE2DR26F8ZLU an order under another contract?
Yes. SPE2DR26F8ZLU is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F8ZLU competed?
The extent of competition for SPE2DR26F8ZLU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award